Dergiler / Turkish journal of vascular surgery / 2021 / Cilt: 30 - Sayı: 3

Long-term results of left subclavian artery coverage during thoracic endovascular aortic repair: A single center study

Sayfa
206–213
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Left-arm ischemia can be treated with carotid-subclavian bypass surgery after LSA occlusion.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objectives: In this study, we aimed to evaluate the results of patients with or without left subclavian artery (LSA) coverage during thoracic endovascular aortic repair (TEVAR) in terms of type IA endoleak.
📊
Temel Bulgular & Veri:Patients and methods: Between December 2011 and March 2020, a total of 50 patients (42 males, 8 females; mean age: 65.2±12.0 years; range, 53.2 to 77.2 years) who underwent TEVAR in our clinic were retrospectively analyzed.
💡
Sonuç & Katkı:Left-arm ischemia can be treated with carotid-subclavian bypass surgery after LSA occlusion.
🔬Tür:Araştırma Makalesi
📍Kapsam:2011 Verileri
⚙️Değişkenler:Alan Parametreleri

Özet

Objectives: In this study, we aimed to evaluate the results of patients with or without left subclavian artery (LSA) coverage during thoracic endovascular aortic repair (TEVAR) in terms of type IA endoleak. Patients and methods: Between December 2011 and March 2020, a total of 50 patients (42 males, 8 females; mean age: 65.2±12.0 years; range, 53.2 to 77.2 years) who underwent TEVAR in our clinic were retrospectively analyzed. The patients were divided into two groups Group 1 (n=34) including patients whose LSA was not covered and Group 2 (n=16) whose LSA was covered by an endograft during the procedure. Primary outcome measures were all-cause mortality and type IA endoleak. Results: Indications were mostly type B aortic dissection (n=15, 30%) (Group 1 n=7, Group 2 n=8) and descending thoracic aortic aneurysms (n=15, 28%) (Group 1 n=11, Group 2 n=4) (p=0.605). The mean follow-up for all patients was 18±12.2 months (p=0.26). Overall mortality was 10% (5/50) and all were in Group 1 (n=5/0), indicating no statistically significant difference between the groups (p=0.11). During follow-up, type IA leak was detected in five patients and was found to be more frequent in Group 2 (n=1/4) (p=0.02). None of the patients had a cerebrovascular accident and spinal cord ischemia during follow-up. Conclusion: The coverage of the LSA during TEVAR may pose a risk for type IA leakage. Left-arm ischemia can be treated with carotid-subclavian bypass surgery after LSA occlusion.

🔖

Bu Makaleye Atıf Yap

KARAARSLAN, K., KUNT, A. G., SAYDAM, O., ŞEREFLİ, D., ABUD, B. (2021). Long-term results of left subclavian artery coverage during thoracic endovascular aortic repair: A single center study. Turkish journal of vascular surgery, Cilt: 30 - Sayı: 3, 206–213. https://ajindex.com/articles/411157

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Grabenwöger M, Alfonso F, Bachet J, Bonser R, Czerny M, Eggebrecht H, et al. Thoracic Endovascular Aortic Repair (TEVAR) for the treatment of aortic diseases: A position statement from the European Association for Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur J Cardiothorac Surg 2012;42:17-24
  2. Dake MD, Kato N, Mitchell RS, Semba CP, Razavi MK, Shimono T, et al. Endovascular stent-graft placement for the treatment of acute aortic dissection. N Engl J Med 1999;340:1546-52
  3. Riambau V, Böckler D, Brunkwall J, Cao P, Chiesa R, Coppi G, et al. Editor's choice - management of descending thoracic aorta diseases: Clinical practice guidelines of the European Society for Vascular Surgery (ESVS). Eur J Vasc Endovasc Surg 2017;53:4-52
  4. Manetta F, Newman J, Mattia A. Indications for thoracic endovascular aortic repair (TEVAR): A brief review. Int J Angiol 2018;27:177-84
  5. Kuo EC, Veranyan N, Johnson CE, Weaver FA, Ham SW, Rowe VL, et al. Impact of proximal seal zone length and intramural hematoma on clinical outcomes and aortic remodeling after thoracic endovascular aortic repair for aortic dissections. J Vasc Surg 2019;69:987-95
  6. Chung J, Corriere MA, Veeraswamy RK, Kasirajan K, Milner R, Dodson TF, et al. Risk factors for late mortality after endovascular repair of the thoracic aorta. J Vasc Surg 2010;52:549-54
  7. Czerny M, Funovics M, Ehrlich M, Hoebartner M, Sodeck G, Dumfarth J, et al. Risk factors of mortality in different age groups after thoracic endovascular aortic repair. Ann Thorac Surg 2010;90:534-8
  8. Peterson BG, Eskandari MK, Gleason TG, Morasch MD. Utility of left subclavian artery revascularization in association with endoluminal repair of acute and chronic thoracic aortic pathology. J Vasc Surg 2006;43:433-9
  9. Lee TC, Andersen ND, Williams JB, Bhattacharya SD, McCann RL, Hughes GC. Results with a selective revascularization strategy for left subclavian artery coverage during thoracic endovascular aortic repair. Ann Thorac Surg 2011;92:97-102
  10. Matsumura JS, Lee WA, Mitchell RS, Farber MA, Murad MH, Lumsden AB, et al. The Society for Vascular Surgery Practice Guidelines: Management of the left subclavian artery with thoracic endovascular aortic repair. J Vasc Surg 2009;50:1155-8
  11. McBride CL, Dubose JJ, Miller CC 3rd, Perlick AP, Charlton-Ouw KM, Estrera AL, et al. Intentional left subclavian